Health Trials

Therapeutic Recommendations for Nephroblastoma

ConditionNephroblastoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-18
SponsorFrench Africa Pediatric Oncology Group

About this trial

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

All children with local Nephroblastoma in all participating units

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Data collection

    Other intervention

    Clinical stage, treatment given and observations of toxicity if any, outcome following treatment and follow up.

Treatment groups

1,000 Participants
are divided into 1 treatment group
Group A: Children with Nephroblastoma1 intervention

Trial outcomes

Primary outcomes

1

Evaluation of the number of cases with local disease.

By evaluating the initial clinical reports and later histological reports to confirm the stage and the diagnosis.

Time frame
5 years
2

Evaluation of the number of cases with stage IV disease.

By evaluating the initial clinical reports and later histological reports to confirm the stage.

Time frame
5 Years
3

Evaluating the treatment given.

Comparison of treatment given and recommended treatment.

Time frame
5 Years
4

Evaluating the follow up after treatment.

How many children alive or dead after treatment

Time frame
5 Years

Secondary outcomes

1

Why has treatment failed

look at precision of reporting by comparing reports (histological and surgical)

Time frame
5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

French Africa Pediatric Oncology Group

Lead sponsor

Source ClinicalTrials.gov
Apply now